Wall Street News Network: Information on stocks, bonds, real estate, investments, gold, startups, & money
RR Auction, a Boston, Massachusetts based auction house, recently sold an Apple 1 Computer prototype.
This very rare Apple (AAPL) technology collectable was hammered at $677,196.
The name of the winner was no disclosed, but he is from the San Francisco Bay Area.s
In 1976, Steve Jobs showed the prototype to the owner of The Byte Shop in Mountain View, California
by Fred Fuld III
If you like to collect or invest in rare cars, here is a unique opportunity. It may not be an electric vehicle, but it is a one of a kind car.
The black 1985 Ford Escort RS Turbo S1 owned by Diana, Princess of Wales, is up for auction.
This was her last Ford Escort, has only 24,961 miles on it.
The automobile is being offered by Silverstone Auctions, with no reserve.
The live auction will take place on Saturday, August 27, 2022.
by Fred Fuld III
If you have not heard of BDCs, they may6 be worth a look. BDC stands for Business Development Company.
BDCs are closed-end investment funds that invest in small and mid-sized businesses, either through equity investments, debt, or both.
They avoid double taxation, similar to REITs, as long as at least 90% of earnings are distributed to shareholders. There is no taxation at the corporate level.
Many income investors like to invest in BDCs for their income, with dividend yields as high as 11%.
One example of a high income BDC is Ares Capital (ARCC), a Los Angeles based company that offers a yield of 8.8%. This BDC has a market cap of $10 billion and pays its dividend quarterly.
Another high yield BDC is Golub Capital BDC (GBDC), which pays a yield of 8.76%. It also has a quarterly dividend payment schedule. This New York City based company has a market cap of $2.4 billion.
There are actually ten BDCs that yield over 8%, with one yielding 11%. In addition, three of the stocks pay dividends monthly.
The entire list of 10 BDC stocks paying over 8% will be emailed to all subscribers this weekend, on Saturday, August 13, 2022. If you are not a subscriber, you can sign up at the signup box below. Don’t miss out. Remember, it’s free!
Of course, there is aways risk, especially since the BDCs invest in smaller companies.
Don’t forget to check out:
Stocks going ex-dividend in August
Disclosure: Author didn’t own any of the above at the time the article was written.
by Fred Fuld III
If you had a baseball card and it had increased in value by 2363%, would you sell it?
Well the owner of a Honus Wagner baseball card did just that.
He paid $294,338 for it back in 2006, and recently sold it through a private sale for $7.25 million.
This works out to an average annual return of 22%.
This extremely rare slabbed Honus Wagner T-206 baseball card was authenticated by SGC.
The back of the card displays an ad for Sweet Caporal Cigarettes.
Honus Wagner, born Johannes Peter Wagner, was an American baseball shortstop who played 21 seasons in Major League Baseball from 1897 to 1917, almost entirely for the Pittsburgh Pirates.
Wagner won his eighth (and final) batting title in 1911, a National League record that remains unbroken to this day, and matched only once, in 1997, by Tony Gwynn. He also led the league in slugging six times and stolen bases five times.
Wagner was nicknamed “the Flying Dutchman” due to his superb speed and German heritage.
In 1936, the Baseball Hall of Fame inducted Wagner as one of the first five members. He received the second-highest vote total, behind Ty Cobb’s 222 and tied with Babe Ruth at 215.
Most baseball historians consider Wagner to be the greatest shortstop ever and one of the greatest players ever. Ty Cobb himself called Wagner “maybe the greatest star ever to take the diamond”.
Wagner was a non-smoker and reportedly didn’t want his card to promote cigarets, so production of the cards was stopped, with less than 60 known to exist.
If you have an interest in baseball and other sports cards, don’t forget to check out the following articles:
Investing in Old Collectable Baseball Cards: How to Get a Share for Free
Last month I bought a Racehorse, an NFT, and a Collectable Baseball Card: Are We In a Bubble?
FOR IMMEDIATE RELEASE
Omaha, NE (BRK.A; BRK.B) –
August 6, 2022
BERKSHIRE HATHAWAY INC. NEWS RELEASE
Berkshire’s operating results for the second quarter and first six months of 2022 and 2021 are summarized in the following paragraphs. However, we urge investors and reporters to read our 10-Q, which has been posted at www.berkshirehathaway.com. The limited information that follows in this press release is not adequate for making an informed investment judgment.
Earnings of Berkshire Hathaway Inc. and its consolidated subsidiaries for the second quarter and first six months of 2022 and 2021 are summarized below. Earnings are stated on an after-tax basis. (Dollar amounts are in millions,
Generally Accepted Accounting Principles (“GAAP”) require that we include the changes in unrealized gains/losses of our equity security investments as a component of investment gains/losses in our earnings statements. In the table above, investment gains (losses) in 2022 include losses of $53.0 billion in the second quarter and $53.8 billion in the first six months and in 2021 include gains of $21.0 billion in the second quarter and $23.8 billion in the first six months due to changes during the second quarter and the first six months in the unrealized gains that existed in our equity security investment holdings. Investment gains (losses) in 2022 also include after-tax realized gains on sales of investments of $44 million in the second quarter and after-tax realized losses of $568 million in the first six months and in 2021 include after-tax realized gains on sales of investments of $183 million in the second quarter and $1.6 billion in the first six months.
The amount of investment gains/losses in any given quarter is usually meaningless and delivers figures for net earnings per share that can be extremely misleading to investors who have little or no knowledge of accounting rules.
An analysis of Berkshire’s operating earnings follows (dollar amounts are in millions).
Second Quarter First Six Months
Approximately $1.0 billion was used to repurchase Berkshire shares during the second quarter of 2022, bringing the six-month total to $4.2 billion. At June 30, 2022, insurance float (the net liabilities we assume under insurance contracts) was approximately $147 billion, relatively unchanged from yearend 2021.
Use of Non-GAAP Financial Measures
This press release includes certain non-GAAP financial measures. The reconciliations of such measures to the most comparable GAAP figures in accordance with Regulation G are included herein.
Berkshire presents its results in the way it believes will be most meaningful and useful, as well as most transparent, to the investing public and others who use Berkshire’s financial information. That presentation includes the use of certain non-GAAP financial measures. In addition to the GAAP presentations of net earnings, Berkshire shows operating earnings defined as net earnings exclusive of investment and derivative gains/losses and impairments of goodwill and intangible assets.
Although the investment of insurance and reinsurance premiums to generate investment income and investment gains or losses is an integral part of Berkshire’s operations, the generation of investment gains or losses is independent of the insurance underwriting process. Moreover, as previously described, under applicable GAAP accounting requirements, we are required to include the changes in unrealized gains/losses of our equity security investments as a component of investment gains/losses in our periodic earnings statements. In sum, investment gains/losses for any particular period are not indicative of quarterly business performance.
About Berkshire
Berkshire Hathaway and its subsidiaries engage in diverse business activities including insurance and reinsurance, utilities and energy, freight rail transportation, manufacturing, retailing and services. Common stock of the company is listed on the New York Stock Exchange, trading symbols BRK.A and BRK.B.
Cautionary Statement
Certain statements contained in this press release are “forward looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are not guaranties of future performance and actual results may differ materially from those forecasted.
by Fred Fuld III
In previous articles, we’ve alerted you to the sale of Elvis Presley‘s childhood house, Steve Job’s autograph on a floppy disk, and a 712 acre Bahamas island.
How would you like to own Buzz Aldrin’s FLOWN Inflight Coverall Jacket, which he wore on his mission to the Moon and back during Apollo 11?
Well you can. You also have the opportunity to buy many other space items.
Sotheby’s is having their auction on July 26, 2022 at 12 noon EDT in New York.
The featured item is Buzz Aldrin’s jacket. The current bid is $700,000, with an estimated sales price of $1,000,000 to $2,000,000.
Other interesting items up for sale in the Buzz Aldrin: American Icon Auction include Buzz Aldrin’s Lifetime Passes to the National and American Leagues of Major League Baseball which has a current bid of $1300, and the United States flag that was flown to the moon on Apollo 11 currently bid at $17,000,.
One other totally unique item is the broken circuit breaker switch that nearly ended the lives of the Apollo 11 Crew, and the pen that saved them, now bid at $700,000.
There are a total of 69 different lot to choose from in this auction.
What a way to bring space home with you.
by Fred Fuld III
Do you want to live forever? Many billionaires want to, or at least want to support the research into improving and extending the lives of people.
Paul Allen, co-founder of Microsoft (MSFT) created the Allen Institute for Cell Science with $100 million, to develop treatments for diseases related to aging. Unfortunately, he passed away in 2018 from septic shock caused by cancer.
Peter Thiel, co-founder of PayPal (PYPL), has donated money to the SENS Research Foundation, a longevity organization.
Adam Neumann, former CEO of WeWork, invested in the anti-aging company Life Biosciences.
Google (GOOG) (GOOGL) co-founder Sergey Brin has donated to the Michael J. Fox Foundation and to the Parkinson’s Institute.
There are many companies involved in longevity and life extension through several different approaches, including medical devices, biotechnology, pharmaceuticals, and senior care facilities.
The anti-aging industry is experiencing tremendous growth. The life extension industry is projected by economists to exceed $1 trillion by 2025.
Biotechnology companies are helping people to live longer than ever. This is due in part to efforts in the field of life extension science, which focuses on developing cutting-edge technologies for extending human life. Three technologies of importance in this field are DNA tests to aid in disease prevention, stem cell research, and gene therapy.
Stem cells allow fetuses to grow complete organs from a single cell. They are used in research to grow transplantable organs. In recent years, scientists have been able to grow replacement body parts and functioning organs. In certain situations, these organs have been successfully transplanted into human patients. Scientists expect that, as this technology continues to advance, the survival rate of patients needing organ transplants will increase dramatically.
One of the challenges in the efforts toward human life extension includes genetic defects that cause fatal diseases. Current research for combating these diseases includes modifying the structure of human DNA through gene therapy. Using gene therapy, scientists can repair damaged DNA by implanting genetic components into human cells.
Some people can inherit a much greater chance of contracting fatal illnesses. With DNA testing, scientists can pinpoint individual genes that cause a high likelihood of developing a specific disease. When locating these harmful genes, fatal diseases can be prevented or treated early enough to prevent death.
Industry experts predict that, at the current rate of advancement, the anti-aging industry may soon surpass that of traditional disease-treating healthcare.
There are several companies working on helping you achieve a greater longevity, which are involved in targeting human aging and degenerative diseases. Here are several that are close to longevity pure plays.
Lineage Cell Therapeutics, Inc. (LCTX) develops and markets therapies for the treatment of various degenerative diseases including age-related macular degeneration, acute spinal cord injuries, non-small cell lung cancer, and various other diseases and disorders. The stock has a market cap of $270 million.
Unity Biotechnology, Inc. (UBX), is a biotechnology company involved in the research and development of therapeutics to extend human life and health. The company’s lead drug candidates include treatments for musculoskeletal/ osteoarthritis disease, moderate-to-severe osteoarthritis of the knee, diabetic macular edema, and ophthalmologic diseases. The stock has a market cap of $47 million.
Cohbar (CWBR) is a clinical stage biotechnology company which concentrates on the research and development of mitochondria based therapeutics, an emerging class of drugs for the treatment of chronic and age-related diseases.
CohBars therapeutics offer the potential to treat a broad range of diseases, including nonalcoholic steatohepatitis, obesity, fibrotic diseases, cancer, acute respiratory distress syndrome, type 2 diabetes, and cardiovascular and neurodegenerative diseases. This Menlo Park, California based company was founded in 2007. The stock has a market cap of $16 million.
AgeX Therapeutics, Inc. (AGE) is an Alameda, California based biotechnology company founded in 2017, with a great stock ticker symbol.The company develops and commercializes novel therapeutics targeting human aging.
The company’s two major proprietary technologies can generate pluripotent stem cell-derived young cells of any type for potential application in a range of degenerative diseases of aging with a high unmet medical need. The company has a longevity platform with a goal of unlocking cellular immortality and regenerative capacity to reverse age-related changes in the body. The stock has a market cap of $27 million.
Adicet Bio, Inc. (ACET), has merged with resTORbio, Inc., a Boston, Massachusetts based company founded in 2016, which is involved in developing innovative medicines that target aging to prevent or treat aging-related diseases.
The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and enhance persistence for durable activity in patients. The stock has a market cap of $682 million.
If you are looking for a more diversified way of investing in this arena, there is the ARK Genomic Revolution ETF (ARKG), which invests in companies involved in genomics.
Please be aware that the above mentioned stocks are extremely low cap companies and should be considered very speculative.
There are some large companies involved in longevity and anti-aging.
One company that fits into this category is Edwards Lifesciences (EW), a California based company involved in the production of products to treat heart disease. This $63.7 billion market cap company trades at 41 times trailing earnings.
Boston Scientific (BSX), a $54.5 billion market cap company, makes and markets an extensive array of cardiology products. The stock has a trailing price-to-earnings ratio of 73.
Vertex Pharmaceuticals Incorporated (VRTX) developer and markets treatments for cystic fibrosis. This $71.7 billion market cap stock trades at 30 times earnings.
Terumo Corporation (TRUMY), based in Japan, makes and markets numerous medical products, primarily for transfusion and cardiothoracic surgery. The $29 billion market cap stock has a PE ratio of 39.
One other related narrow industry in this area is CRISPR. If you are not familiar with what this is, you can check out our CRISPR article.
Just be aware that many of the stocks involved in gene therapy, stem cells, and CRISPR are very low cap companies and therefore, very speculative.
Hopefully, one or more of these stocks will provide you with great returns over a long and healthy life. Who knows? You may not live forever, but at least to the age to 200 or 300.
Disclosure : Author didn’t own any of the above at the time the article was written. No recommendations are expressed or implied.
by Fred Fuld III
Investors continue to look for high yields on their money. One option that many consider are high yield equity REITs.
A REIT is a Real Estate Investor Trust. A REIT is a company that owns and typically operates income-producing real estate or related assets, such as real estate mortgages.
Properties may include office buildings, shopping malls, apartments, hotels, resorts, self-storage facilities, warehouses, and mortgages or loans.
Unlike other real estate companies, a REIT does not develop real estate properties to resell them. Instead, a REIT buys and develops properties primarily to operate them as part of its own investment portfolio.
REITS are required to pay out at least 90% of their taxable income to shareholders as dividends each year. However, most REITS pay out at least 100 percent of their taxable income to their shareholders.
The big advantage of REITs is that they avoid double taxation. They are generally not taxed at the corporate level, unlike corporations.
This tends to boost the payout rates for REITs, compared to stocks that are registered as corporations.
There are two primary types of REITs: equity REITs and mortgage REITs.
Equity REITs own the actual buildings and land.
Mortgage REITs own mortgages on the properties. Last week, we published an article on large cap stocks paying over 10% which included some mortgage REITs.
Our researchers have turned up four equity REITs that are currently yielding over 10%.
Office Properties Income Trust (OPI) owns, operates, and leases properties to single tenants especially those with excellent credit such as government entities. The annual dividend rate is 11.18%, payable quarterly, and the stock is trading at 65% of book value. Quarterly revenue growth was 2% year-over-year. Earnings have dropped.
Presidio Property Trust (SQFT), which has a great stock ticker symbol, is diversified both geographically and by real estate type, with a portfolio that includes office, industrial, retail and model home residential properties.
The stock pays a dividend yield of 13.59% and the price to book value is 0.21. Earnings per share growth this year was 45.4%; however revenues have been down.
Global Net Lease (GNL) pays a 10.69% yield. Quarterly revenue growth was up 8.6% year-over-year. Quarterly earnings growth rose by an incredible 571.5% year-over-year.
The company has a a diversified global portfolio of commercial properties in the United States and Europe.
Generation Income Properties (GIPR) has a diversified portfolio of office, industrial and retail high quality single tenant properties. The stock pays 10.39%.
Quarterly revenues were up 33.3% and quarterly earnings increased by 71.9%.
Don’t forget to check out the article on stocks going ex-dividend in August.
Disclosure: Author didn’t own any of the above at the time the article was written.
The following is a short list of some of the many stocks going ex dividend during the next month.
Many traders and investors use the stock trading technique called ‘Buying Dividends,’ also commonly referred to as ‘Dividend Capture.’ This is the strategy of buying stocks before the ex dividend date and selling the stock shortly after the ex date at about the same price, yet still being entitled to the dividend.
This technique generally works in bull markets and flat or choppy markets, but during bear markets, you may want to consider avoiding this strategy. In order to be entitled to the dividend, you have to buy the stock before the ex-dividend date, and you can’t sell the stock until on or after the ex date.
The actual dividend may not be paid for another few weeks. WallStreetNewsNetwork.com has compiled a downloadable list of the stocks going ex dividend in the near future. The list contains many dividend paying companies, lots with market caps over $500 million. Some of the stocks have yields over 2%. Here are a few examples showing the stock symbol, the ex-dividend date, the periodic dividend amount, and the annual yield.
| Intel Corporation (INTC) | 8/4/2022 | 0.365 | 3.63% |
| MetLife, Inc. (MET) | 8/8/2022 | 0.50 | 3.29% |
| Starbucks Corporation (SBUX) | 8/11/2022 | 0.49 | 2.37% |
| Target Corporation (TGT) | 8/16/2022 | 1.08 | 2.82% |
| Lockheed Martin Corp (LMT) | 8/31/2022 | 2.80 | 2.87% |
The entire list of over 120 ex-dividend stocks will be emailed to all subscribers early next week, on Tuesday, July 26, 2022. If you are not a subscriber, you can sign up at the signup box below. Don’t miss out. Remember, it’s free!
Declaration date: the day that the company declares that there is going to be an upcoming dividend.
Ex-dividend date: the day on which if you buy the stock, you would not be entitled to that particular dividend; or the first day on which a shareholder can sell the shares and still be entitled to the dividend.
Record date: the day when you must be on the company’s books as a shareholder to receive the dividend. The ex-dividend date is normally set for stocks at two business days before the record date.
Payment date: the day on which the dividend payment is actually made, which can be as long at two months after the ex date.
Don’t forget to reconfirm the ex-dividend date with the company before implementing this technique.
Disclosure: Author did not own any of the above at the time the article was written; affiliate links are on this page.
Are you concerned about your stocks tanking when they report earnings? Or may you re hoping for a spike in price.
It is going to be a busy week coming up due to company earnings announcements.
The following are a list of stocks that are reporting their earnings next week.
Please note: some may be reporting before the stock market opens and some may report after the market close.
| Company | Symbol | Date |
| Starbucks Corp | SBUX | Tue, July 26 |
| JetBlue Airways Corp | JBLU | Tue, July 26 |
| Coca-Cola Co | KO | Tue, July 26 |
| McDonald’s Corp | MCD | Tue, July 26 |
| 3M Co | MMM | Tue, July 26 |
| General Electric Co | GE | Tue, July 26 |
| Visa Inc Class A | V | Tue, July 26 |
| Microsoft Corp | MSFT | Tue, July 26 |
| Texas Instruments Inc | TXN | Tue, July 26 |
| Alphabet Inc Class A | GOOGL | Tue, July 26 |
| Alphabet Inc Class C | GOOG | Tue, July 26 |
| CME Group Inc lass A | CME | Wed, July 27 |
| Etsy Inc | ETSY | Wed, July 27 |
| Southern Co | SO | Thur, July 28 |
| Honeywell International Inc | HON | Thur, July 28 |
| Altria Group Inc | MO | Thur, July 28 |
| Tilray Brands Inc | TLRY | Thur, July 28 |
| Apple Inc | AAPL | Thur, July 28 |
| Amazon.com Inc | AMZN | Thur, July 28 |
| Caterpillar Inc | CAT | Fri, July 29 |
| Exxon Mobil Corp | XOM | Fri, July 29 |
